Both in Pharmaceuticals
Decoy Therapeutics vs PMGC Holdings
Over the past year DCOY returned −80.8% and ELAB returned −99.0%; their daily moves had a correlation of -0.22.
DCOY −80.8% ELAB −99.0%Growth of $1, one year, split-adjusted
| Metric | DCOY | ELAB |
|---|---|---|
| Price | $1.77 | $3.36 |
| Market cap | $1.2M | $2.7M |
| Today | −4.58% | +4.19% |
| 1 month | −40.6% | −34.0% |
| 6 months | −69.5% | −94.1% |
| Year to date | — | −99.1% |
| 1 year | — | −99.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | 29.5% |
| Net margin | −1042.8% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.1× |
| Net cash | $8.3M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 126.0% | 677.2% |
| Short % of float | 0.2% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).